Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study
Published inAntiviral therapy, vol. 3, no. Suppl 4, p. 65-67
Publication date1998
Abstract
Keywords
- Anti-HIV Agents/adverse effects/therapeutic use
- CD4 Lymphocyte Count
- Didanosine/adverse effects/ therapeutic use
- Drug Synergism
- Drug Therapy, Combination
- Follow-Up Studies
- HIV Infections/ drug therapy
- Hiv-1
- Humans
- Hydroxyurea/adverse effects/ therapeutic use
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/adverse effects/therapeutic use
- Stavudine/adverse effects/ therapeutic use
Citation (ISO format)
RUTSCHMANN, Olivier Thierry et al. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study. In: Antiviral therapy, 1998, vol. 3, n° Suppl 4, p. 65–67.